Pathophysiology and Clinical Diagnoses: A Comprehensive Review

Graves Disease

Graves disease is an autoimmune form of hyperthyroidism. The pathology involves autoantibodies that stimulate TSH receptors, leading to excess $T_3$ and $T_4$ production. A distinct clinical manifestation is exophthalmos (bulging eyes). This occurs because the autoantibodies also trigger orbital fibroblast activation, leading to glycosaminoglycan deposition and subsequent edema behind the eyes.

Exam Tip: When distinguishing between thyroid disorders, remember that primary disorders originate in the thyroid gland (e.g., high TSH with low $T_4$), whereas secondary disorders originate in the pituitary (e.g., low TSH with low $T_4$).

Gastrointestinal Disorders

The GI tract is susceptible to both mechanical obstructions and inflammatory damage.

GERD and its Complications

Gastroesophageal reflux disease (GERD) is caused by impaired lower esophageal sphincter (LES) tone, allowing gastric acid to reflux into the esophagus and even the larynx. Chronic acid exposure can lead to significant structural changes:

• Barrett’s Esophagus: A process of metaplasia where the esophageal lining changes to accommodate acid.
• Peptic Strictures: Fibrosis resulting from chronic esophagitis, which causes progressive dysphagia (difficulty swallowing), particularly with solids.

Peptic Ulcer Disease (PUD)

PUD occurs when aggressive factors (acid, H. pylori, or NSAIDs) overwhelm the stomach's protective mechanisms, such as mucus and bicarbonate secretion. A major risk factor is the use of NSAIDs (e.g., aspirin), which inhibit prostaglandin synthesis. Since prostaglandins are essential for maintaining mucosal blood flow and protective secretions, their inhibition leaves the gastric mucosa vulnerable to erosion.

Inflammatory Bowel Disease (IBD)

It is vital to differentiate between the two primary types of IBD:

1. Ulcerative Colitis: Characterized by continuous mucosal inflammation that begins in the rectum and extends proximally.
2. Crohn's Disease: Characterized by transmural inflammation (affecting all layers of the bowel wall) and the presence of skip lesions, meaning inflammation can occur in any part of the GI tract with healthy segments in between.

Psychiatric Disorders and Neurochemistry

Psychiatric diagnoses are increasingly understood through the lens of neurotransmitter and hormonal dysregulation.

Major Depressive Disorder (MDD)

MDD presents with symptoms such as anhedonia (loss of interest), fatigue, and sleep disturbances. Pathophysiologically, it is linked to:

• Neurotransmitter imbalances: Specifically involving serotonin, dopamine, and norepinephrine.
• HPA Axis Dysregulation: Chronic hyperactivation of the hypothalamic-pituitary-adrenal (HPA) axis leads to elevated cortisol levels, which can eventually reduce hippocampal neurogenesis.

Bipolar I Disorder

Bipolar I is defined by the occurrence of manic episodes. These episodes feature euphoria, impulsivity, and a decreased need for sleep, often driven by dopamine and norepinephrine dysregulation.

Generalized Anxiety Disorder (GAD)

GAD is characterized by excessive, uncontrollable worry. It is linked to serotonin dysregulation and reduced alpha-adrenergic receptor binding. SSRIs (Selective Serotonin Reuptake Inhibitors), such as escitalopram, are considered first-line pharmacologic treatments to stabilize these pathways.

Clinical Correlation: When treating a patient with Bipolar Disorder, clinicians must be cautious when prescribing SSRIs, as they can potentially precipitate a manic episode if not paired with a mood stabilizer.